> News >
NOF CORPORATION attends CPhI India 2010 in Mumbai, India on December 1st-3rd
NOF release New Activated PEG
NOF Activated PEG Used in an U.S. FDA Approved PEGylated Drug
NOF exhibits cutting edge excipients & tech. for DDS in CPhI
Program for Liposome Conference in Vancouver, Aug 4-8, 2010
NOF presents at Liposome Conference in Vancouver, Aug 4-8, 2010
Agenda for Novel Nanodelivery of siRNA/miRNA Symposium at CNSI, UCLA
NOF cosponsors Novel Nanodelivery of siRNA/miRNA Symposium at CNSI, UCLA
NOF AMERICA CORPORATION opened a new office in California
Please print and register Exhibit Hall Pass for 2010 CRS, July 12-14, Portland OR, US, Booth#303
NOF exhibits cutting-edge excipients & tech. for DDS in CRS, July 12-14, Portland OR, US Booth#303
NOF attends 2010 AAPS National Biotechnology Conference on May 17 - 18, 2010 in San Francisco
Print Coupon for TIDES 2010 in Boston, MA; NOF participates in the exhibition at Booth# 406.
NOF participates in the exhibition "TIDES 2010" in Boston, MA; Booth# 406
NOF Expands Capacity for Activated PEG
NOF partners with ENZON on PEG derivatives
NOF signs Exclusive Licensing Agreement on Novel Carrier for Gene Delivery
Copyright(c) NOF CORPORATION.
All rights reserved.
Use Terms and Conditions